dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Jimenez-Fonseca, Paula |
dc.contributor.author | Martínez de Castro, Eva |
dc.contributor.author | Custodio, Ana |
dc.contributor.author | Pericay, Carles |
dc.contributor.author | Hernández, Raquel |
dc.contributor.author | Diez Garcia, Marc |
dc.contributor.author | Carmona-Bayonas, Alberto |
dc.date.accessioned | 2022-06-28T10:25:07Z |
dc.date.available | 2022-06-28T10:25:07Z |
dc.date.issued | 2021-03 |
dc.identifier.citation | Jimenez-Fonseca P, Carmona-Bayonas A, Martínez de Castro E, Custodio A, Pericay Pijaume C, Hernandez R, et al. External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? Gastric Cancer. 2021 Mar;24:445–56. |
dc.identifier.issn | 1436-3305 |
dc.identifier.uri | https://hdl.handle.net/11351/7737 |
dc.description | Model bayesià; Docetaxel; Càncer gàstric |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Gastric Cancer;24 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Estómac - Càncer - Tractament |
dc.subject | Estadística bayesiana |
dc.subject | Anàlisi de supervivència (Biometria) |
dc.subject.mesh | Stomach Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Progression-Free Survival |
dc.subject.mesh | Bayes Theorem |
dc.title | External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s10120-020-01116-x |
dc.subject.decs | neoplasias gástricas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | supervivencia libre de progresión |
dc.subject.decs | teorema de Bayes |
dc.relation.publishversion | https://doi.org/10.1007/s10120-020-01116-x |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Jimenez-Fonseca P] Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain. [Carmona-Bayonas A] Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain. Fundación Séneca, Murcia, Spain. [Martínez de Castro E] Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. [Custodio A] Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain. [Pericay Pijaume C] Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain. [Hernandez R] Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain. [Diez M] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 32970266 |
dc.identifier.wos | 000572609700002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |